PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLEK.L Regulatory News (LEK)

  • There is currently no data for LEK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Loan - Update

10 Mar 2021 13:45

RNS Number : 8314R
Lekoil Limited
10 March 2021
 

10 March 2021

Lekoil Limited

("LEKOIL" or the "Company")

 

Director Loan - Update

LEKOIL (AIM: LEK), the oil and gas exploration and production company with a focus on Nigeria and West Africa, announces that the Board of the Company has decided to apply a portion of the salary payable to Mr. Olalekan Akinyanmi, a director of the Company, towards the repayment of the loan provided to him by the Company (the "Loan") as contemplated within the amendment to the agreement as announced on 18 December 2020 (the "Amended Loan Agreement").

Under the terms of the Amended Loan Agreement, Mr. Akinyanmi was due to make the second instalment payment of US$413,523 on or before 9 March 2021. As the Company has not received this payment, the following action under the terms of the amended loan agreement has been initiated such that a portion of the salary payable to Mr. Akinyanmi shall be applied towards the Loan, as agreed in the Amended Loan Agreement as a method of default recovery, until the repayment schedule is satisfied. As the Company considers the Loan to be in default, under the agreement, an additional interest of 4% per annum will be applied to amounts in arrears under the agreed payment schedule. As at 9 March 2021, the outstanding balance of the Loan provided to Mr. Akinyanmi was approximately US$1.5 million. In applying this arrangement, the Company's reserves its rights under the Loan agreement, without prejudice, and at law.

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

For further information, please visit www.lekoil.com or contact:

LEKOIL Limited

Hamilton Esi, Corporate Communications

Ore Bajomo, Investor Relations

+44 20 7457 2020

SP Angel Corporate Finance LLP (Nominated Adviser and Joint Broker)

John Mackay / Jeff Keating / Stuart Gledhill / Richard Hail

 

+44 20 3470 0470

Tennyson Securities (Joint Broker)

Peter Krens / Edward Haig-Thomas

+44 20 7186 9030

Instinctif (Financial PR)

Mark Garraway / Galyna Kulachek / Sarah Hourahane

+44 20 7457 2020

lekoil@instinctif.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBXGDXRXBDGBG
Date   Source Headline
10th Sep 20214:13 pmRNSHolding(s) in Company
10th Sep 202112:47 pmRNSDirector Loan - Update
8th Sep 202112:42 pmRNSCorporate update
2nd Sep 202112:17 pmRNSConvertible Facility Agreement
2nd Sep 20219:05 amRNSSecond Price Monitoring Extn
2nd Sep 20219:00 amRNSPrice Monitoring Extension
2nd Sep 20217:00 amRNSCorporate & Operational Update
1st Sep 20214:40 pmRNSSecond Price Monitoring Extn
1st Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20212:05 pmRNSSecond Price Monitoring Extn
1st Sep 20212:00 pmRNSPrice Monitoring Extension
1st Sep 202111:59 amRNSHolding(s) in Company
31st Aug 20214:40 pmRNSSecond Price Monitoring Extn
31st Aug 20214:35 pmRNSPrice Monitoring Extension
10th Aug 202111:06 amRNSSecond Price Monitoring Extn
10th Aug 202111:00 amRNSPrice Monitoring Extension
5th Jul 20214:40 pmRNSSecond Price Monitoring Extn
5th Jul 20214:35 pmRNSPrice Monitoring Extension
5th Jul 20212:06 pmRNSSecond Price Monitoring Extn
5th Jul 20212:00 pmRNSPrice Monitoring Extension
2nd Jul 20214:41 pmRNSSecond Price Monitoring Extn
2nd Jul 20214:35 pmRNSPrice Monitoring Extension
2nd Jul 20212:05 pmRNSSecond Price Monitoring Extn
2nd Jul 20212:00 pmRNSPrice Monitoring Extension
23rd Jun 20217:00 amRNSChange of website address
21st Jun 20213:30 pmRNSResignation of CFO
18th Jun 202112:53 pmRNSDirectorate Change
17th Jun 20217:00 amRNSDelay in publication of Annual Results for 2020
10th Jun 20217:00 amRNSCorporate Update
3rd Jun 20217:00 amRNSDirectorate Change
17th May 20217:00 amRNSAward of Options
20th Apr 20217:07 amRNSDirectorate Change
15th Apr 20218:15 amRNSDirectorate Change
26th Mar 20217:00 amRNSTrading and operational update
12th Mar 20214:41 pmRNSSecond Price Monitoring Extn
12th Mar 20214:36 pmRNSPrice Monitoring Extension
10th Mar 20211:45 pmRNSDirector Loan - Update
26th Feb 20217:00 amRNSTR-1: notification of major holdings
24th Feb 20217:00 amRNSRe Cost and Revenue Sharing Agreement for OPL 310
4th Feb 20214:40 pmRNSSecond Price Monitoring Extn
4th Feb 20214:35 pmRNSPrice Monitoring Extension
13th Jan 20217:00 amRNSJoint Broker Appointment
11th Jan 20217:00 amRNSAppointment of Chairman
8th Jan 202112:28 pmRNSResult of EGM
8th Jan 20217:00 amRNSRE Extraordinary General Meeting
7th Jan 20211:20 pmRNSResponse to Press Speculation
31st Dec 202012:43 pmRNSJoint Broker Resignation
29th Dec 20202:06 pmRNSSecond Price Monitoring Extn
29th Dec 20202:01 pmRNSPrice Monitoring Extension
22nd Dec 20206:05 pmRNSAppointment of Nominated Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.